bpc 157 regulatory status fda 2025 Is BPC-157 Legal in 2026? Compounding Explained FDA's Overreach on Compounded Peptides
Description
the RDA is 2.4 g/d
83 Cancer
- , BPC-157
For most first-time users, topical at 1 to 2% delivers visible results without the regulatory complications around compounded injectables
There's also a real tissue risk with repeated injections: cortisone can weaken collagen fibers in tendons over time and cause fat pad atrophy at the heel the very cushioning you need. A single, well-timed cortisone injection does have a role, and I'll explain when I use one
